Search - Prime Therapeutics

457 Results for GLP-1 Pipeline Update

Prime/MRx real-world GLP-1 persistence and adherence data published in Journal of Managed Care & Specialty Pharmacy

Among the key findings from the study — among 4,066 members, Prime/MRx found 1 in 3 stayed on their GLP-1 and 27% took their medication as intended

PA Sub-Categories: GLP-1 Prime Article: Stories
Looking to lose weight in 2024? Watch for counterfeit GLP-1 drugs

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares how to identify fake GLP-1s

PA Sub-Categories: GLP-1 Prime Article: Perspectives
Forbes: Cost Savings From GLP-1 Weight Loss Drugs Still Elusive

Forbes: Injectable glucagon-like peptide-1 agonists, or GLP-1s, were first approved as diabetes medications 20 years ago

PA Sub-Categories: GLP-1 Prime Article: In the News
AMCP Nexus in focus: Exploring Prime’s GLP-1 research in depth

Ben Urick, senior director of health outcomes, and Landon Marshall, health outcomes research principal, share more about their educational session and research poster on GLP-1s

PA Sub-Categories: GLP-1 Prime Article: Perspectives